Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma I...

FDA Drug Recall #D-0166-2021 — Class I — November 25, 2020

Recall Summary

Recall Number D-0166-2021
Classification Class I — Serious risk
Date Initiated November 25, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Torrent Pharma Inc
Location Levittown, PA
Product Type Drugs
Quantity 2496 Bottles

Product Description

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide USA and Puerto Rico

Lot / Code Information

Batch BFD1G001, exp 12/2021

Other Recalls from Torrent Pharma Inc

Recall # Classification Product Date
D-0852-2022 Class II Pantoprazole Sodium Delayed-Release Tablets, US... Apr 11, 2022
D-1371-2019 Class II Nasal Decongestant Liquid, Pseudoephedrine HCl,... May 21, 2019
D-1367-2019 Class II Kid Kare Childrens Cough/Cold Liquid, Antihista... May 21, 2019
D-1375-2019 Class II Memantine Hydrochloride Oral Solution, 2 mg/mL,... May 21, 2019
D-1357-2019 Class II Biscolax Laxative (Bisacodyl, USP 10 mg), a) 12... May 21, 2019

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.